Milestone Pharmaceuticals Inc
(MIST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -41,301 | -29,322 | -16,343 | -55,229 | -36,940 |
| Depreciation Amortization | 72 | 49 | 24 | 38 | 14 |
| Other Working Capital | -4,261 | -7,540 | -2,741 | 2,848 | 1,540 |
| Other Operating Activity | 3,515 | 2,172 | 981 | 1,191 | 837 |
| Operating Cash Flow | $-41,975 | $-34,641 | $-18,079 | $-51,152 | $-34,549 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -56,000 | -32,000 | N/A | 29 | -29,971 |
| PPE Investments | N/A | N/A | N/A | -413 | -312 |
| Investing Cash Flow | $-56,000 | $-32,000 | $N/A | $-384 | $-30,283 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 25,067 | 249 | 77 | 85,407 | 85,386 |
| Financing Cash Flow | $25,067 | $249 | $77 | $85,407 | $85,386 |
| Beginning Cash Position | 119,818 | 119,818 | 119,818 | 85,947 | 85,947 |
| End Cash Position | 46,910 | 53,426 | 101,816 | 119,818 | 106,501 |
| Net Cash Flow | $-72,908 | $-66,392 | $-18,002 | $33,871 | $20,554 |
| Free Cash Flow | |||||
| Operating Cash Flow | -41,975 | -34,641 | -18,079 | -51,152 | -34,549 |
| Capital Expenditure | N/A | N/A | N/A | -413 | -312 |
| Free Cash Flow | -41,975 | -34,641 | -18,079 | -51,565 | -34,861 |